http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-307341-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a138b6d825fccb7edde90a055b9f984 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| filingDate | 2017-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d11505744956ab67cc3c67e7b659d12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2172d14c9b8ed41b1ad13e46e712f1e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15547bac08fe1a2254cf3d3f76af09a |
| publicationDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-307341-B6 |
| titleOfInvention | Pharmaceutical composition and method for its preparation |
| abstract | The present invention provides a pharmaceutical formulation comprising an oxime capable of reactivating organophosphate-inhibited acetylcholinesterase, and cucurbit [7] uril. This pharmaceutical combination enhances the permeation of the oxime across the hermetic barrier without the need to interfere with its structure, i.e., without reducing efficacy. Further, the absolute bioavailability of the oxime is significantly increased. The present invention further provides a method of preparing such a pharmaceutical composition and its use in treating poisoning caused by organophosphorus inhibitors. |
| priorityDate | 2017-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.